Search for: "James E. Lyons v. State" Results 21 - 33 of 33
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Nov 2012, 11:54 am
Many courts, including the United States Supreme Court, have recognized a private cause of action for violation of NASD and NYSE Rules, including a private cause of action for andldquo;the failure to supervise.andrdquo;andnbsp; See, e.g., Cook v. [read post]
26 Nov 2007, 7:49 am
Box 308 Faribault, MN 55021-0308 Phone: (507) 332-5491 (V/TTY); (800) 657-3936 (V/TTY/Toll Free) DEAF, Inc. 413 Wacouta Street Suite 300 St. [read post]
26 Jan 2023, 7:45 pm by Jim Sedor
Supreme Court said it cannot identify the person who in the spring leaked a draft of the opinion that overturned Roe v. [read post]
4 Jul 2012, 8:52 am by Carolina Bracken
Looking to Strasbourg jurisprudence, he commented, “[t]he ECtHR will only find that the state has acted in violation of A1P1” if its judgment is “manifestly without reasonable foundation” (James v United Kingdom (1986) 8 EHRR 123). [read post]
12 Mar 2012, 8:13 am by Ronald Collins
  I took the liberty of saying “yes” as in, for example, James F. [read post]
3 Jul 2023, 4:07 am by INFORRM
On 29 June 2023, judgment was handed down in R v Dent, 2023 ONCA 460. [read post]
7 May 2015, 11:31 am by Schachtman
In 1996, another working group of the IARC met in Lyon, France, to deliberate on the classification of crystalline silica. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]